The Continued Role for COVID Testing
Currently, in the U.S. COVID testing mostly occurs in persons showing symptoms (test-to-treat). Could we navigate in person meetings, the work place, family gatherings more safely if we were to (rapid) test everyone before getting together (test-to-stay)? Some countries around the world were using this path. And many countries are reconsidering their testing strategy again as COVID cases continue to rise, including in Germany where tests are now being offered for free again.
We will discuss this with one of the most sought after German politicians and health experts as well as with leading scientists.
- Karl Lauterbach, M.D., Sc.D., Member of the German Parliament, Professor of Health Economics and Clinical Epidemiology at the University of Cologne
- Michael Mina, M.D., Ph.D., Chief Science Officer, eMed
- Melanie Ott, M.D., Ph.D., Director, Gladstone Institute of Virology, Professor of Medicine at the University of California San Francisco
- Stefanie Friedhoff, Assistant Professor of the Practice, Brown University School of Public Health
- Jan Hartmann, M.D., President German-American Business Council of Boston, and Chief Medical Officer, Haemonetics Corporation (moderator)